Covington Capital Management Gilead Sciences, Inc. Transaction History

Covington Capital Management

$23.2 Billion
Q3 2022

A detailed history of Covington Capital Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Covington Capital Management holds 4,792 shares of GILD stock, worth $442,828. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,792

Previous 4,737 1.16%

Holding current value

$442,828

Previous $293,000 1.02%

% of portfolio

0.0%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $3,274 - $3,740	55 Added 1.16%	4,792 $296,000
Q2 2022 Jul 08, 2022	SELL	$57.72 - $65.01 $18,124 - $20,413	-314 Reduced 6.22%	4,737 $293,000
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $828,777 - $1.04 Million	-14,309 Reduced 73.91%	5,051 $300,000
Q4 2021 Feb 16, 2022	BUY	$64.88 - $73.64 $15,311 - $17,379	236 Added 1.23%	19,360 $1.41 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $6,769 - $7,303	-100 Reduced 0.52%	19,124 $1.34 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $13,709 - $14,979	-216 Reduced 1.11%	19,224 $1.32 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $6,540 - $7,462	-109 Reduced 0.56%	19,440 $1.26 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $29,741 - $33,888	-525 Reduced 2.62%	19,549 $1.14 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $17,795 - $20,664	-246 Reduced 1.21%	20,074 $1.54 Million
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $37,578 - $48,132	600 Added 3.04%	20,320 $1.52 Million
Q4 2019 Feb 18, 2020	SELL	$61.62 - $67.78 $212,897 - $234,179	-3,455 Reduced 14.91%	19,720 $1.28 Million
Q3 2019 Nov 18, 2019	SELL	$62.51 - $69.0 $52,820 - $58,305	-845 Reduced 3.52%	23,175 $1.47 Million
Q2 2019 Aug 15, 2019	SELL	$61.87 - $69.38 $120,646 - $135,291	-1,950 Reduced 7.51%	24,020 $1.62 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $204,410 - $228,993	-3,269 Reduced 11.18%	25,970 $1.69 Million
Q4 2018 Feb 15, 2019	BUY	$60.54 - $79.0 $61,448 - $80,185	1,015 Added 3.6%	29,239 $1.83 Million
Q3 2018 Nov 15, 2018	SELL	$71.28 - $78.92 $153,252 - $169,678	-2,150 Reduced 7.08%	28,224 $2.18 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $478,684 - $558,367	-7,378 Reduced 19.54%	30,374 $2.15 Million
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $204,316 - $249,084	-2,805 Reduced 6.92%	37,752 $2.85 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $32,017 - $37,584	-450 Reduced 1.1%	40,557 $2.91 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $5,696 - $6,752	79 Added 0.19%	41,007 $3.32 Million
Q2 2017 Aug 16, 2017	BUY	N/A	40,928	40,928 $2.9 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covington Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Covington Capital Management with notifications on news.

Account

Covington Capital Management Gilead Sciences, Inc. Transaction History